Resultados de búsqueda - Chess~

  1. 301
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313
  14. 314

    Effect of dark sweet cherry powder consumption on the gut microbiota, short-chain fatty acids, and biomarkers of gut health in obese db/db mice por García Mazcorro, José Francisco, Lage, Nara N., Mertens Talcott, Susanne U., Talcott, Stephen, Chew, Boon, Dowd, Scot E., Kawas Garza, Jorge R., Noratto, Giuliana D.

    Publicado 2018
    “…According to 16S sequencing, supplemented mice harbored a distinct colonic microbiota characterized by a higher abundance of mucin-degraders (i.e., Akkermansia) and fiber-degraders (theS24-7family)aswellaslowerabundancesofLactobacillusandEnterobacteriaceae. …”
    Enlace del recurso
    Artículo
  15. 315
  16. 316
  17. 317

    Medical devices in allergy practice por Popov, Todor A., Passalacqua, Giovanni, González Díaz, Sandra Nora, Plavec, Davor, Braido, Fulvio, García Abujeta, Jose Luis, Dubuske, Lawrence M., Rouadi, Philip W., Morais Almeida, Mario, Bonini, Sergio, Cheng, Lei, Ansotegui, Ignacio J.

    Publicado 2020
    “…Different medical specialties use varieties of medical devices more or less specific for them. Allergology is an interdisciplinary field of medical science and teaches that allergic reactions are of systemic nature but can express themselves at the level of different organs across the life cycle of an individual. …”
    Enlace del recurso
    Artículo
  18. 318

    Interferon-based therapy delays but metabolic comorbidity accelerates progression of chronic hepatitis C por Martínez Macías, Roberto F., Cordero Pérez, Paula, Juárez Rodríguez, Omar A., Chen López, Carlos Y., Martínez Carrillo, Francisco M., Alarcón Galván, Gabriela, Mercado Hernández, Roberto, Muñoz Espinosa, Linda Elsa

    Publicado 2015
    “…Treated patients showed less progression of liver disease. Treated patients showed less progression of liver disease; and older patients, those with metabolic comorbidities, with MELD score ≥ 18 and APRI ≥ 1.5 exhibited adverse effects.…”
    Enlace del recurso
    Artículo
  19. 319
  20. 320

Herramientas de búsqueda: